Genentech Usa, Inc. Federal Spending Profile
Genentech Usa, Inc. is a mid-sized federal recipient, with $449.6M in total federal obligations spread across 10 awards reported on USAspending.gov. That places Genentech Usa, Inc. #199 among federal contractors ranked by total obligations.
Every one of Genentech Usa, Inc.'s 10 federal awards is a procurement contract rather than a grant — the company sells goods or services to the government rather than receiving grant funding.
Genentech Usa, Inc.'s federal business is heavily concentrated in one customer: Department of Health and Human Services accounts for roughly 99% of its top-agency obligations, with Department of Defense a distant second. Across the full record the company works with 2 agencies, but a single relationship dominates the dollars.
What the federal government buys from Genentech Usa, Inc. is led by Transportation & Logistics ($60.0M), followed by Other Services ($22.0M); together these categories describe the goods and services the company is paid to deliver.
Its largest single recent award is a $22.0M contract from the Department of Health and Human Services, described in the federal record as "Xofluza (Baloxavir Marboxil)."
Track Genentech Usa, Inc.
Subscribe for TaxDollarData updates by email. No spam, unsubscribe anytime.
Spending by Agency
Recent Awards
| Description | Agency | Start Date | Amount |
|---|---|---|---|
| THE PURPOSE AND NEED FOR THIS PROPOSED REQUIREMENT IS TO PROVIDE THE DIVISION OF STRATEGIC NATIONAL STOCKPILE (DSNS), ASSISTANT SECRETARY OF PREPAREDNESS AND RESPONSE (ASPR), WITH A CONTRACTING VEHICLE FOR PRODUCT(S) NEEDED IN ORDER TO SUPPORT " | Department of Health and Human Services | Sep 14, 2022 | $60.0M |
| XOFLUZA (BALOXAVIR MARBOXIL) | Department of Health and Human Services | Sep 30, 2024 | $22.0M |
| 8510632021!OTHER MEDICAL | Department of Defense | May 15, 2024 | $544K |
| 8509885034!OTHER MEDICAL | Department of Defense | May 11, 2023 | $542K |
| 4565476087!TNKASE 50 MG KITS | Department of Defense | Aug 15, 2024 | $16K |
| 4565423661!ACTIVASE 50 MG VIAL W/DILUENT FOR INJECT | Department of Defense | Aug 7, 2024 | $3K |
| 4565423659!ACTIVASE 50 MG VIAL W/DILUENT FOR INJECT | Department of Defense | Aug 7, 2024 | $3K |
| 4565249515!ACTIVASE 50 MG VIAL W/DILUENT FOR INJECT | Department of Defense | Jul 23, 2024 | $3K |
| 4565249516!ACTIVASE 50 MG VIAL W/DILUENT FOR INJECT | Department of Defense | Jul 23, 2024 | $3K |
| EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING TAMIFLU 75MG CAPSULES (NDC 0004-0800-85) AND TAMIFLU 30MG CAPSULES (NDC 0004-0802-85) | Department of Health and Human Services | Nov 17, 2023 | - |
All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.
Genentech Usa, Inc. Federal Contracts FAQ
Genentech Usa, Inc. has received $449,571,673 in total federal obligations across 10 awards and 10 contracts.
Genentech Usa, Inc. works with 2 federal agencies, including Department of Health and Human Services, Department of Defense. The largest agency relationships are based on total dollar obligations.
Genentech Usa, Inc. has received federal awards in multiple states.
Genentech Usa, Inc. is ranked #199 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.
Explore Other Federal Contractors
Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.